STOCK TITAN

Kestra Medical Technologies, Ltd. (KMTS) S-3 Filings

KMTS NASDAQ

Here are the S-3 shelf registrations from Kestra Medical Technologies, Ltd. (KMTS) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

An S-3 covers the shelf registration that lets an established company sell over time, so if you follow KMTS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full KMTS filings page.

Rhea-AI Summary

Kestra Medical Technologies, Ltd. filed an automatic shelf registration on April 1, 2026 to offer and sell common shares from time to time under Form S-3 as a well‑known seasoned issuer. The prospectus permits offerings in amounts, at prices and on terms to be determined in each prospectus supplement, with sales commencing from time to time after the registration statement is declared effective.

The prospectus describes the company’s Cardiac Recovery System and its ASSURE WCD wearable defibrillator — which has been worn by over 33,000 patients as of January 2026 — and provides customary risk factors, tax discussions (Bermuda, Irish, and U.S. federal), plan of distribution options, and corporate governance and capital structure details. The prospectus discloses Nasdaq listing under the symbol KMTS and a last reported closing price of $19.93 per share on March 31, 2026.